Markus Otto

Martin Luther University Halle-Wittenberg (DE)

Research Areas

MedicineBiologyInternal medicinePathologyPsychologyNeuroscienceChemistryGenetics

Discover Papers by Markus Otto

Access 250+ million papers and cite this researcher's work with AI assistance

Try AnswerThis Free →

H-index

Publications

1082

Citations

28738

i10-index

379

Publications & Citations Over Time

Top Cited Publications

Want to find and read papers by this researcher? AnswerThis gives you instant access.

Title	Year	Citations
Neurofilaments as biomarkers in neurological disor...	2018	1548
Haploinsufficiency of TBK1 causes familial ALS and...	2015	712
Blood GFAP as an emerging biomarker in brain and s...	2022	470
Detection of 14‐3‐3 protein in the cerebrospinal f...	1998	441
Advantages and disadvantages of the use of the CSF...	2019	440
The Alzheimer's Association external quality contr...	2011	394
Guillain–Barré syndrome spectrum associated with C...	2020	390
Elevated levels of tau-protein in cerebrospinal fl...	1997	340
Autoimmune psychosis: an international consensus o...	2019	325
Value of CSF β-amyloid1–42 and tau as predictors o...	2003	297

Publications

1.
Neurofilaments as biomarkers in neurological disorders
Year: 2018Citations: 1548DOI: 10.1038/s41582-018-0058-z
2.
Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia
Year: 2015Citations: 712DOI: 10.1038/nn.4000
3.
Blood GFAP as an emerging biomarker in brain and spinal cord disorders
Year: 2022Citations: 470DOI: 10.1038/s41582-021-00616-3
4.
Detection of 14‐3‐3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt‐Jakob disease
Year: 1998Citations: 441DOI: 10.1002/ana.410430109
5.
Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
Year: 2019Citations: 440DOI: 10.1186/s13195-019-0485-0
6.
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
Year: 2011Citations: 394DOI: 10.1016/j.jalz.2011.05.2243
7.
Guillain–Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases
Year: 2020Citations: 390DOI: 10.1007/s00415-020-10124-x
8.
Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease
Year: 1997Citations: 340DOI: 10.1016/s0304-3940(97)00215-2
9.
Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin
Year: 2019Citations: 325DOI: 10.1016/s2215-0366(19)30290-1
10.
Value of CSF β-amyloid1–42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment
Year: 2003Citations: 297DOI: 10.1038/sj.mp.4001473

About Markus Otto

Markus Otto is a researcher with 1082 publications and 28738 citations. They are affiliated with Martin Luther University Halle-Wittenberg. Their research focuses on Medicine, Biology, Internal medicine and other areas. With an h-index of 92, they are among the top researchers in their field.

Citation Distribution

Distribution of citations across publications

Research Smarter

AnswerThis uses AI to help you search, understand, and cite research from Markus Otto and 250M+ other papers.

AI-powered research assistance
Automatic citations and references
Advanced academic writing tools

Research Area Breakdown

Publication Types

Publication type data not available

Impact Metrics Over Time

Citations per publication by year